Last week, PEMAC’s Head of Customer Success, Andrew Smith, delivered PEMAC ASSETS Application Core training to CMMS users at the Autolus Therapeutics commercial manufacturing facility, in Stevenage, UK.
This cross-functional training was attended by six of our client’s representatives and was prompted by a recent upgrade and expansion (incl. future planned expansion) of PEMAC ASSETS CMMS software across the 70,000 square foot production site.
Application Core Training for Autolus
This was a highly interactive 2-day course dedicated to fully training, upskilling, and optimising use of PEMAC ASSETS software across the Autolus Stevenage site. All six training delegates were educated on best practice use of CMMS and provided with in-depth tutorials on the new features included within PEMAC ASSETS v4.0, as well as detailed instructions for deployment.
The PEMAC ASSETS Application Core training course was tailored specifically for individual user groups across Autolus, and covered the following key areas:
User Group | Responsibility |
IT Application Support | Taking ownership of PEMAC ASSETS CMMS software and its administration across Autolus. |
Maintenance Scheduling | Use PEMAC ASSETS to collaborate with production schedulers on the planning of various maintenance outages. |
Maintenance Technicians | Effectively managing all work orders assigned to them within the PEMAC ASSETS CMMS software. |
Quality Assessors | Part of the validation team responsible for upgrading Autolus to the latest version of PEMAC ASSETS software (version v4.0). |
CPD Accreditation for PEMAC CMMS Training
All Autolus course participants were presented with official CPD Standards Office certificates and awarded 14 CPD hours on successful completion of the PEMAC ASSETS Application Core training.
Learn more about PEMAC’s recent CPD Accreditation
Upcoming CMMS Application Core Training
PEMAC is now accepting registrations for our next Application Core public training course which will be held online between 27-28 November 2024. Click here for more information.
If you would like to discuss custom CMMS training options for your own team, please email sales@pemac.com
For more details on PEMAC ASSETS training courses, please visit our Training page.
About Autolus Therapeutics
Autolus is a global CAR T cell therapy company with a presence in the UK, Germany, Switzerland and the USA.
The company applies extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases.
In 2023, Autolus completed the build of a 70,000 square foot commercial manufacturing facility, The Nucleus, in Stevenage, UK. The facility has been designed to manufacture and test approximately 2,000 batches per year with expansion opportunities. Click here to learn more about Autolus.